MAPT and Alzheimer disease: The first PET tracers of tau pathology were developed almost a decade ago.1 These tracers have advanced our understanding of the role of tau pathology in aging and Alzheimer’s disease.2-5 However, several questions remain, including the spatial progression of the disease across the whole brain.